ID   Ba/F3 EGFR-S768I [Yonsei University]
AC   CVCL_E6D4
SY   Ba/F3 hEGFR S768I
RX   PubMed=39874964;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Ser768Ile (c.2303G>T)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=39874964; DOI=10.1016/j.xcrm.2025.101929;
RA   Oh S.Y., Park S., Lee S., Lee E.J., Kim T.H., Choi S.-J., Park S.Y.,
RA   Kim J.H., Lim S.M., Lee J.B., Cho B.C., Hong M.H., Yun M.R.;
RT   "The potential of lazertinib and amivantamab combination therapy as a
RT   treatment strategy for uncommon EGFR-mutated NSCLC.";
RL   Cell Rep. Med. 6:101929.1-101929.12(2025).
//